NeueHealth, Inc.
NEUE
$5.99
-$0.50-7.70%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 133.92% | 193.15% | -14.67% | -72.83% | -145.92% |
| Total Other Revenue | 89.85% | 124.80% | 149.12% | 489.65% | 237.66% |
| Total Revenue | 237.73% | 1,024.76% | 45.83% | -28.96% | -130.07% |
| Cost of Revenue | 241.58% | 7,638.02% | 34.64% | -24.14% | -129.33% |
| Gross Profit | 214.55% | 203.82% | 338.23% | -57.42% | -135.46% |
| SG&A Expenses | 4,669.88% | 80.55% | 3.50% | -15.12% | -99.02% |
| Depreciation & Amortization | -10.71% | -10.30% | 4.09% | -17.36% | -3.79% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 301.45% | 478.43% | 23.39% | -21.46% | -121.36% |
| Operating Income | -56.19% | 33.42% | 20.70% | -11.64% | 65.88% |
| Income Before Tax | -203.31% | 15.23% | 4.58% | -36.36% | 54.17% |
| Income Tax Expenses | -190.69% | -109.87% | 118.84% | 145.47% | 143.84% |
| Earnings from Continuing Operations | -191.14% | 16.20% | -0.24% | -51.28% | 51.08% |
| Earnings from Discontinued Operations | -79.48% | -247.47% | -1,489.03% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -48.63% | -103.31% | -322.79% | -1,372.42% | -1,502.43% |
| Net Income | 0.00% | 18.98% | -6.73% | -23.75% | -199.76% |
| EBIT | -56.19% | 33.42% | 20.70% | -11.64% | 65.88% |
| EBITDA | -76.12% | 34.16% | 20.15% | -12.92% | 70.79% |
| EPS Basic | 16.76% | 31.65% | 18.78% | 13.48% | -47.01% |
| Normalized Basic EPS | -258.83% | -42.22% | -5.53% | -21.78% | 89.44% |
| EPS Diluted | 16.76% | 31.65% | 18.78% | 13.48% | -47.01% |
| Normalized Diluted EPS | -258.83% | -42.22% | -5.53% | -21.78% | 89.44% |
| Average Basic Shares Outstanding | 11.19% | 10.79% | 38.98% | 90.06% | 113.37% |
| Average Diluted Shares Outstanding | 11.19% | 10.79% | 38.98% | 90.06% | 113.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
